G93.31
Postviral fatigue syndrome
Postviral fatigue syndrome (PVFS) is a debilitating clinical condition characterized by chronic, profound exhaustion that follows a viral infection. Unlike standard post-infectious recovery, PVFS involves a significant decline in functional capacity and is often marked by post-exertional malaise (PEM), where symptoms worsen significantly after even minor physical or cognitive exertion. While it is classified alongside myalgic encephalomyelitis and chronic fatigue syndrome, G93.31 specifically designates cases where the onset is clearly linked to a viral event. The pathophysiology is complex, involving persistent neuroinflammation, immune system dysregulation (such as chronic cytokine release), mitochondrial dysfunction leading to impaired cellular energy production, and disturbances in the autonomic nervous system. Patients often experience a 'waxing and waning' course of illness, where periods of relative stability are interrupted by severe relapses triggered by stress or activity. Diagnosis is primarily clinical, focusing on the temporal relationship between a viral illness and the subsequent emergence of characteristic fatigue and systemic symptoms that persist for weeks or months.
Clinical Symptoms
- Profound, persistent fatigue not relieved by rest
- Post-exertional malaise (symptom exacerbation following activity)
- Cognitive dysfunction (brain fog, impaired memory, and concentration)
- Unrefreshing or disturbed sleep patterns
- Myalgia (diffuse muscle pain)
- Arthralgia (joint pain without swelling or redness)
- Orthostatic intolerance (dizziness or lightheadedness upon standing)
- Headaches of a new type, pattern, or severity
- Persistent sore throat
- Tender cervical or axillary lymph nodes
- Heart palpitations or tachycardia
- Thermodysregulation (feeling excessively hot or cold)
- Sensory hypersensitivity (sensitivity to light, sound, or chemicals)
- Irritability or emotional lability
Common Causes
- Epstein-Barr virus (Infectious Mononucleosis)
- Human Herpesvirus 6 (HHV-6)
- SARS-CoV-2 (COVID-19)
- Cytomegalovirus (CMV)
- Coxsackievirus and other Enteroviruses
- Influenza viruses
- Persistent low-grade neuroinflammation
- Dysregulated immune response and cytokine signaling
- Mitochondrial metabolic impairment
- Autonomic nervous system instability (Dysautonomia)
- Hypothalamic-pituitary-adrenal (HPA) axis dysfunction
Documentation & Coding Tips
Explicitly identify the preceding viral infection to support the postviral diagnosis.
Example: Patient presents with persistent, profound exhaustion following a laboratory-confirmed Epstein-Barr virus infection six months ago. Documentation notes that fatigue is not relieved by rest and significantly limits the patient's prior level of occupational and social functioning, supporting G93.31 as the primary driver of the encounter.
Billing Focus: Documentation must specify the causal link between a previous viral illness and the current fatigue state to satisfy ICD-10-CM instructional notes.
Document Post-Exertional Malaise (PEM) as a hallmark symptom of G93.31.
Example: The patient reports a severe exacerbation of symptoms including cognitive dysfunction and physical exhaustion 24 hours after mild physical activity. This PEM lasts for several days and is documented as a core diagnostic criterion for postviral fatigue syndrome.
Billing Focus: PEM is a specific clinical indicator that differentiates G93.31 from general malaise (R53.81) or depressive episodes.
Incorporate the results of objective autonomic testing if performed.
Example: Review of systems reveals significant orthostatic intolerance. Orthostatic vitals show a heart rate increase of 35 bpm upon standing without a drop in blood pressure, consistent with Postural Orthostatic Tachycardia Syndrome (POTS) secondary to postviral fatigue syndrome.
Billing Focus: Laterality and specific physiological manifestations must be documented to support the medical necessity of diagnostic testing.
Differentiate between Postviral Fatigue Syndrome and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Example: While the patient meets criteria for ME/CFS, the current presentation is specifically characterized by the onset immediately following an acute viral respiratory infection, thus G93.31 is selected to reflect the post-infectious etiology.
Billing Focus: Correct code selection between G93.31 (Postviral) and G93.32 (ME/CFS) depends on whether the clinician attributes the condition to a specific viral antecedent.
Quantify the duration and impact on Activities of Daily Living (ADLs).
Example: The patient has been unable to perform basic household chores for over 6 months due to neurological fatigue. Prior to the viral illness, the patient was fully independent. Current status requires assistance with meal preparation and shopping.
Billing Focus: Documenting chronicity (6 months or longer) is often required by payers for the diagnosis of chronic fatigue-related syndromes.
Note the exclusion of other medical and psychiatric causes of fatigue.
Example: Extensive workup including TSH, CBC, CMP, and sleep study was unremarkable for alternative causes of chronic exhaustion. Clinical picture remains most consistent with G93.31 following viral pneumonia.
Billing Focus: Supports the medical necessity of the G93.31 code as the definitive diagnosis after a process of elimination.
Relevant CPT Codes
-
99214 - Office or other outpatient visit for the evaluation and management of an established patient, moderate MDM, 30-39 minutes
G93.31 usually requires moderate MDM to manage chronic symptoms, review diagnostic exclusions, and coordinate multi-disciplinary care.
-
99215 - Office or other outpatient visit for the evaluation and management of an established patient, high MDM, 40-54 minutes
Used for patients with severe functional impairment, multiple comorbidities, or during an acute exacerbation requiring extensive management.
-
99213 - Office or other outpatient visit for the evaluation and management of an established patient, low MDM, 20-29 minutes
Appropriate for stable follow-up visits focused on single symptom management or medication refills.
-
95921 - Autonomic strategy neuro-physiologic evaluation; cardiovagal innervation
Used to assess the autonomic dysfunction frequently reported by patients with G93.31.
-
96132 - Neuropsychological testing evaluation services by physician or other qualified health care professional, first hour
Necessary to objectively document the brain fog and cognitive deficits associated with PVFS.
-
97802 - Medical nutrition therapy; initial assessment and intervention, individual, face-to-face, each 15 minutes
Many PVFS patients benefit from anti-inflammatory diets or specific nutritional supplementation.
-
93000 - Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report
Used to rule out cardiac causes of fatigue and palpitations during the initial workup.
-
99457 - Remote physiologic monitoring treatment management services, first 20 minutes per month
Useful for tracking activity levels and heart rate variability to prevent Post-Exertional Malaise.
-
90834 - Psychotherapy, 45 minutes with patient
Used for managing the significant emotional burden and secondary depression associated with chronic illness.
-
94010 - Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement
Performs as part of the differential workup for shortness of breath or exertion-related fatigue.
Related Diagnoses
- G93.32 - Myalgic encephalomyelitis/chronic fatigue syndrome
- U09.9 - Post COVID-19 condition, unspecified
- R53.83 - Other fatigue
- G90.9 - Disorder of the autonomic nervous system, unspecified
- B94.8 - Sequelae of other specified infectious and parasitic diseases
- F48.0 - Neurasthenia
- G47.00 - Insomnia, unspecified
- R41.840 - Attention and concentration deficit
- M79.7 - Fibromyalgia
- R53.82 - Chronic fatigue, unspecified